Case Control Study to Evaluate the Relationship between Vitamin D Deficiency and Severity of COVID-19 Infection and Outcome

{"title":"Case Control Study to Evaluate the Relationship between Vitamin D Deficiency and Severity of COVID-19 Infection and Outcome","authors":"","doi":"10.47648/jswmc2022v12-02-53","DOIUrl":null,"url":null,"abstract":"Background: Coronavirus disease (COVID-19) is a systemic disorder caused by severe acute respiratory syndrome corona virus (SARS-COV-2). No established curative treatment for this disease is yet invented. Vitamin D deficiency (VDD) significantly facilitates in worsening COVID 19 infections. Till now, there is no definite verification on its impact on COVID-19 infection. Objective: To evaluate the relationship amid vitamin D-deficiency and severity of COVID-19 infection and its outcome. Methods: The present case-control study was conducted at a medical college hospital, Sylhet, Bangladesh. Total 100 cases and 100 controls were enrolled. Patients categorization were formulated on the ground of severity of COVID infection clinically and Vitamin D level at admission. The relationship among these two categories with different variables was analyzed. All data were processed and analyzed by SPSS (statistical package for social science) version 25. Results: In this study the mean age was 58.46 14.50 years in COVID 19 patients (case group) and 41.96 5.66 years in control group. Majority (64%) was male and 36% was female among COVID 19 patients. Leading risk factor (64%) was DM (diabetes mellitus) followed by smoking (24%) and hypertension (16%). Significant vitamin D deficiency was seen in case group (COVID 19) than control group which was 37% and 22% respectively. Further observed, vitamin D insufficiency was also more in case group (39%) than control group (31%). However, sufficient vitamin D levels were more in control group than case group which was 47% and 24% respectively. The average vitamin D level was 24.10 11.30 in case group and 28.55 11.80 in control group which carried significant statistic value (P<0.05). Thus, Vitamin D level was significantly associated with the COVID 19 disease severity evident by 45.1 % deficiency in severe cases compared to 17.2% among the moderate cases. Conclusion: This study shows the serum level of vitamin D was lower in patients with the COVID 19. It is also found that vitamin D status is remarkably related to COVID-19 severity. Vitamin D supplementation may have a vital role in limiting the impact of this pandemic. More clinical studies are demanded to establish the relationship between COVID 19 patients and the serum level of vitamin D.","PeriodicalId":407803,"journal":{"name":"The Journal of Sylhet Women’s Medical College","volume":"70 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Sylhet Women’s Medical College","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47648/jswmc2022v12-02-53","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Coronavirus disease (COVID-19) is a systemic disorder caused by severe acute respiratory syndrome corona virus (SARS-COV-2). No established curative treatment for this disease is yet invented. Vitamin D deficiency (VDD) significantly facilitates in worsening COVID 19 infections. Till now, there is no definite verification on its impact on COVID-19 infection. Objective: To evaluate the relationship amid vitamin D-deficiency and severity of COVID-19 infection and its outcome. Methods: The present case-control study was conducted at a medical college hospital, Sylhet, Bangladesh. Total 100 cases and 100 controls were enrolled. Patients categorization were formulated on the ground of severity of COVID infection clinically and Vitamin D level at admission. The relationship among these two categories with different variables was analyzed. All data were processed and analyzed by SPSS (statistical package for social science) version 25. Results: In this study the mean age was 58.46 14.50 years in COVID 19 patients (case group) and 41.96 5.66 years in control group. Majority (64%) was male and 36% was female among COVID 19 patients. Leading risk factor (64%) was DM (diabetes mellitus) followed by smoking (24%) and hypertension (16%). Significant vitamin D deficiency was seen in case group (COVID 19) than control group which was 37% and 22% respectively. Further observed, vitamin D insufficiency was also more in case group (39%) than control group (31%). However, sufficient vitamin D levels were more in control group than case group which was 47% and 24% respectively. The average vitamin D level was 24.10 11.30 in case group and 28.55 11.80 in control group which carried significant statistic value (P<0.05). Thus, Vitamin D level was significantly associated with the COVID 19 disease severity evident by 45.1 % deficiency in severe cases compared to 17.2% among the moderate cases. Conclusion: This study shows the serum level of vitamin D was lower in patients with the COVID 19. It is also found that vitamin D status is remarkably related to COVID-19 severity. Vitamin D supplementation may have a vital role in limiting the impact of this pandemic. More clinical studies are demanded to establish the relationship between COVID 19 patients and the serum level of vitamin D.
评价维生素D缺乏与COVID-19感染严重程度及预后关系的病例对照研究
背景:冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒(SARS-COV-2)引起的一种全身性疾病。目前还没有发明针对这种疾病的有效治疗方法。维生素D缺乏(VDD)会显著加剧COVID - 19感染。到目前为止,它对新冠病毒感染的影响还没有明确的验证。目的:探讨维生素d缺乏与COVID-19感染严重程度及转归的关系。方法:本病例对照研究在孟加拉国锡尔赫特的一所医学院医院进行。共纳入100例病例和100例对照。根据临床感染严重程度和入院时维生素D水平对患者进行分类。分析了这两类在不同变量下的关系。所有数据均采用SPSS (statistical package for social science)第25版进行处理和分析。结果:病例组的平均年龄为58.46 - 14.50岁,对照组的平均年龄为41.96 - 5.66岁。在COVID - 19患者中,大多数(64%)为男性,36%为女性。主要危险因素是糖尿病(DM)(64%),其次是吸烟(24%)和高血压(16%)。病例组(COVID - 19)明显缺乏维生素D,分别为37%和22%。进一步观察,病例组(39%)的维生素D不足也高于对照组(31%)。然而,对照组的维生素D含量高于病例组分别为47%和24%病例组平均维生素D水平为24.10 11.30,对照组为28.55 11.80,差异有统计学意义(P<0.05)。因此,维生素D水平与COVID - 19疾病严重程度显著相关,重度病例缺乏45.1%,而中度病例缺乏17.2%。结论:新冠肺炎患者血清维生素D水平较低。研究还发现,维生素D水平与COVID-19严重程度显著相关。补充维生素D可能在限制这次大流行的影响方面发挥至关重要的作用。需要更多的临床研究来确定COVID - 19患者与血清维生素D水平的关系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信